Fmoc-O-methyl-L-tyrosine

Fmoc-O-methyl-L-tyrosine is an Fmoc-protected tyrosine derivative in which the phenolic hydroxyl is O-methylated, yielding a protected, non-ionizable aromatic side chain while retaining the L-configuration at the α-carbon. The molecule combines an N-Fmoc carbamate for orthogonal protection during peptide assembly with an O-methyl ether that modulates hydrogen-bonding and oxidative reactivity compared with unprotected tyrosine. The aromatic ring supports electrophilic aromatic substitution and can participate in π-stacking and hydrophobic interactions in peptide and peptidomimetic contexts, while the ester-free amino acid framework remains suitable for standard coupling chemistry after deprotection. The compound functions as a chiral, side-chain-functionalized amino acid building block and synthetic intermediate for constructing tyrosine-containing sequences with controlled side-chain behavior.

1. Peptide Synthesis

Fmoc-O-methyl-L-tyrosine is used in peptide building block preparation for solid-phase peptide synthesis workflows where the Fmoc carbamate enables N-terminal protection and base-mediated deprotection control. The α-amino acid functionality and carboxyl group compatibility support peptide coupling strategies that generate amide bonds while the O-methylated phenyl ether preserves side-chain stability under conditions that would otherwise risk phenolic side reactions. Side-chain O-methylation can reduce phenol oxidation and suppress uncontrolled O-alkylation during multistep assembly, supporting reproducible synthesis of tyrosine analog peptides. Downstream, the resulting peptides can be used as sequence-defined materials for biochemical research, assay development, or structure-focused peptide library generation.

2. Peptidomimetics And SAR

Fmoc-O-methyl-L-tyrosine serves in peptidomimetic construction and structure-activity relationship studies where modulation of the tyrosine side chain affects polarity, conformational preferences, and aromatic interaction patterns. The protected phenolic oxygen as a methyl ether changes hydrogen-bond donor/acceptor properties relative to native tyrosine, which can be leveraged to tune binding-site complementarity in SAR panels. The Fmoc-protected amino acid format facilitates incorporation into larger scaffolds through standard coupling and iterative chain elongation, enabling systematic variation of aromatic residues. The resulting tyrosine-methyl ether analogs can be advanced as chemical probes or lead optimization intermediates for mapping structure-function relationships in peptide-like systems.

3. Side-Chain Functionalization

Fmoc-O-methyl-L-tyrosine is applied to side-chain functionalization strategies in synthetic organic chemistry where the aromatic ring is maintained while the phenolic functionality is masked as an ether. The O-methyl ether can act as a controlled handle for later transformation, since demethylation or selective side-chain modification may be used to access phenolic derivatives when required for downstream conjugation or receptor-binding studies. The Fmoc group provides orthogonal protection during assembly, allowing selective manipulation of the aromatic region after peptide or intermediate formation. The compound therefore supports modular synthesis of tyrosine-derived intermediates used to generate functional analogs, including aromatic-substituted derivatives and protected phenol-containing building blocks.

4. Chemical Biology Probes

Fmoc-O-methyl-L-tyrosine is suitable for chemical biology research requiring tyrosine-positioned probes with reduced phenolic reactivity during labeling and handling. The O-methylated side chain can improve stability against oxidative processes that may complicate probe integrity, while the aromatic ring supports noncovalent interactions used in molecular recognition studies. The Fmoc-protected amino acid enables incorporation into peptide conjugates, enabling site-defined presentation of an aromatic residue within a larger recognition scaffold. Downstream applications include generation of peptide-based affinity reagents, tagging reagents, and sequence-defined probes for studying biomolecular interactions under conditions where free phenols may be less stable.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-O-methyl-L-tyrosine can be employed in pharmaceutical manufacturing-oriented intermediate preparation for producing tyrosine-methyl ether-containing peptide fragments used in process chemistry and scale-up routes. The orthogonally protected N-Fmoc group supports predictable deprotection and coupling steps in manufacturing workflows that rely on robust, reproducible protection-group behavior. The O-methyl ether side chain reduces susceptibility to phenolic side reactions, which can simplify impurity profiles during peptide assembly and downstream processing of protected intermediates. The compound's role as a chiral, protected amino acid building block supports consistent incorporation into controlled sequence segments used for further derivatization, analytical method development, and intermediate isolation in fine chemical production.

6. Analytical Research Standards

Fmoc-O-methyl-L-tyrosine is used in analytical research for preparing reference materials and calibrants related to protected tyrosine derivatives and peptide fragments. The defined stereochemistry and stable O-methyl ether side chain help generate reproducible chromatographic and mass spectrometric signatures compared with phenolic tyrosine analogs that may undergo oxidation or variable derivatization. The Fmoc group provides a traceable protection motif that can be monitored during deprotection and coupling-related process development, supporting method qualification for peptide synthesis analytics. Downstream, the compound can serve as a starting point for generating defined standards used in impurity profiling, identity confirmation, and characterization of amino acid and peptide intermediates.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide